Our Motto

Help, Healing, Happiness

Overview

The will to ensure wellness for all inspires Morepen's R&D team to innovate non-infringing technologies and cost-effective processes in order to achieve world-class quality and high yields for the generic market. Our R&D team's consistent ability to create new polymorphs of complex new molecules not only gives Morepen its unique strategic edge but also enables the company to break fresh grounds and capture new markets locally & globally on the strength of innovation.

Quality Products at Affordable Prices

Capabilities

25+

New molecules in
advance stage of
development

WHO, USFDA
Approved Quality
Controlled Process

54+

Patents Awarded
Globally and
regionally

45+

Drug master files
Published for all APIs with International Standards

A leap Towards a Healthier and Better World

Highly Skilled & dedicated team of R&D at main API plant at Masulkhana / Baddi (HP) with focus on new product Pipeline, cost reduction and new processes. All the products launched so far by the company have been developed in-house and also have a strong pipeline ready. Morepen is now focussing on new product selection with a highly diverse product selection criterion. Now focussed with first-to-file strategy for new molecule selection, Morepen is working on new molecules for ANDA filing

New

Product Development

INNOVATIVE

Non-Infringing Process

Cost

Reduction

Intellectual

Property

Specialized

Chemical Synthesis

Specialized Chemical Synthesis

  • Acetylation/ Alkylation Reaction
  • Amine/ Hydroxy Deprotection
  • Amino Acid Coupling
  • Ester Hydrolysis
  • Chiral Synthesis
  • Heck reaction
  • Peptide coupling reactions
  • Enzymatic / Catalytic reduction
  • Condensation Reaction
  • Cyanation Reaction
  • Grignard Reaction
  • Friedel Craft Reaction
  • Hetero Cyclization
  • High pressure Hydrogenation
  • α, β-Enzymatic Oxidation
  • Reduction Reaction
  • Esterification
  • Nucleophilic Substitution
  • Oxidation Reaction
  • Bromination Reaction
  • Vilsmair Haack Reaction
  •  

Patents and Ip

60+ PATENS FILED, 33+ PATENT GRANTED

ATORVASTATIN CALCIUM

USA, CANADA, RUSSIA, SOUTH AFRICA, AUSTRALIA, JAPAN, INDIA

MONTELUKAST AMORPHOUS PATENT

GLOBAL, USA, CANADA, EUPORE, INDIA

DESLORATADINE

USA, CANADA, EUROPE, INDIA

ROSUVASTATIN

USA, EUROPE, INDIA

Patents granted in india for

  • APIXABAN
  • SITAGLIPTIN PHOSPHATE
  • NEW POLYMORPH OF SITAGLIPTIN PHOSPHATE
  • CRYSTALLIINE ROSUVASTATIN CALCIUM
  • AMORPHOUS ROSUVASTATIN CALCIUM
  • ANHYDROUS ROSUVASTATIN CALCIUM
  • CANDESARTAN CILEXETIL
  • LORATADINE
  • DESLORATADINE
  • VORTIOXETINE HYDROBROMIDE
  • FEXOFENADINE
  • AMORPHOUS EDOXABAN TOSYALTE
  • ALISKIREN HEMIFUMARATE
  • CANAGLIFLOZIN HEMIHYDRATE

Products in Development

Anti-Histaminic
Bilastine
Anti-Diabetic
Imeglimin Hydrochloride
Anti-Psychotic
Cariprazine Hydrochloride
Systolic Heart Failure
Vericiguat
To treat abnormally thick heart muscle
Mavacamten
For prevention of stroke & heart attack
Ticagrelor
Chronic Kidney Disease
Finerenone
Relapsing Remitting multiple sclerosis
Cladribine
For Treatment of Pulmonary Arterial Hypertension (PAH)
Macitentan
Acetylation/ Alkylation Reaction
Dapagliflozin (DP04)
Fexofenadine (D01, D05)
Saxagliptin (SX02)
Amino Acid Coupling
Saxagliptin (SX01)
Sitagliptin (SG05)
Amine/ Hydroxy Deprotection
Atorvastatin (AT09A)
Candesartan (CS06)
Dapagliflozin (DP05)
Fexofenadine (D07)
Linagliptin (LG04)
Olmesartan (OL05)
Rosuvastatin (RT11)
Saxagliptin (SX04, SX05)
Sitagliptin (SG06))
Acetylation/ Alkylation Reaction
Dapagliflozin (DP04)
Fexofenadine (D01, D05)
Saxagliptin (SX01)
Amino Acid Coupling
Saxagliptin (SX01)
Sitagliptin (SG05)
Acetylation/ Alkylation Reaction
Dapagliflozin (DP04)
Fexofenadine (D01, D05)
Saxagliptin (SX02)
Acetylation/ Alkylation Reaction
Dapagliflozin (DP04)
Fexofenadine (D01, D05)
Saxagliptin (SX01)
Acetylation/ Alkylation Reaction
Dapagliflozin (DP04)
Fexofenadine (D01, D05)
Saxagliptin (SX01)
Amino Acid Coupling
Saxagliptin (SX01)
Sitagliptin (SG05)
Acetylation/ Alkylation Reaction
Dapagliflozin (DP04)
Fexofenadine (D01, D05)
Saxagliptin (SX02)
Acetylation/ Alkylation Reaction
Dapagliflozin (DP04)
Fexofenadine (D01, D05)
Saxagliptin (SX01)

Determination to deliver consistent quality with improved processes and detailed analysis and checks.

Quality Control and Assurance

Determination to deliver consistent quality with improved processes and detailed analysis and checks.

  • Detailed SOPs in 28 Chapters
  • Quaterly internal audits by QA
  • External Audit by GMP consultant as required
  • Regular Customer Audits

Let's join hands to work Together